● Recruiting

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Condition: ST Elevated Myocardial Infarction · Dual Antiplatelet Therapy · Sponsor: Research Maatschap Cardiologen Rotterdam Zuid

PhasePhase 4

Planned participants1656

Who can joinAll sexes, N/A to no upper limit

Healthy volunteersNo

About this study

The study is a multi-centre, Open-label, Randomized Controlled, 1:1 trial comparing Prasugrel-based short DAPT (30-45 days) followed by Prasugrel monotherapy versus standard DAPT regimen in STEMI patients in terms of safety and efficacy endpoints. In the subgroup of STEMI patients with MVD, a sub-randomization will allow a comparison between a complete revascularization OCT-guided versus complete revascularization angiography-guided stent in terms of efficacy and safety endpoints.

This description comes directly from the study's public registry record.

Talk to the study team

Valeria Paradies, MD · +31621620153 · paradiesV2@maasstadziekenhuis.nl

Ria van Vliet · +31644162844 · vlietM@maasstadziekenhuis.nl

Always discuss trial participation with your own doctor first.

Locations (27)

Imelda Bonheiden	Bonheiden, Belgium	Recruiting
AZ St.Jan	Bruges, Belgium	Recruiting
ZOL Genk	Genk, Belgium	Recruiting
UZ Leuven	Leuven, Belgium	Recruiting
AZ Delta	Roeselare, Belgium	Recruiting
FN BRNO	Brno, Czechia	Recruiting
Masaryk Hospital Usti nad Labem -	Hradec Králové, Czechia	Recruiting
Charles University Hospital	Prague, Czechia	Not Yet Recruiting
Asklepios Klinik Bad Oldesloe	Bad Oldesloe, Germany	Recruiting
Segeberger Kliniken	Bad Segeberg, Germany	Recruiting
University hospital Dresden	Dresden, Germany	Recruiting
Ospedale Papa Giovanni XXIII	Bergamo, Italy	Recruiting

+ 15 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05491200